Back
Akebia Therapeutics, Inc. Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
35
AKBA
Akebia Therapeutics, Inc.
Last Price:
$1.60
Seasonality Move:
43.42%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKBA is experiencing slight buying pressure.
Akebia Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.56 | Buy |
| 20-day SMA: | 1.67 | Sell |
| 50-day SMA: | 2.31 | Sell |
| 200-day SMA: | 2.72 | Sell |
| 8-day EMA: | 1.57 | Buy |
| 20-day EMA: | 1.74 | Sell |
| 50-day EMA: | 2.17 | Sell |
| 200-day EMA: | 2.54 | Sell |
Akebia Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 36.06 | Sell |
| Chaikin Money Flow: | 1199254 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.53 - 1.99) | Sell |
| Bollinger Bands (100): | (2.11 - 3.49) | Sell |
Akebia Therapeutics, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akebia Therapeutics, Inc. Stock
Is Akebia Therapeutics, Inc. Stock a Buy?
-
Akebia Therapeutics, Inc. share price is 1.59 while AKBA 8-day simple moving average is 1.56, which is a Buy signal.
-
The stock price of AKBA is 1.59 while Akebia Therapeutics, Inc. 20-day SMA is 1.67, which makes it a Sell.
-
Akebia Therapeutics, Inc. 50-day simple moving average is 2.31 while AKBA share price is 1.59, making it a Sell technically.
-
AKBA stock price is 1.59 and Akebia Therapeutics, Inc. 200-day simple moving average is 2.72, creating a Sell signal.
AKBA Technical Analysis vs Fundamental Analysis
Sell
35
Akebia Therapeutics, Inc. (AKBA)
is a Sell
Is Akebia Therapeutics, Inc. a Buy or a Sell?
-
Akebia Therapeutics, Inc. stock is rated a SellThe current Akebia Therapeutics, Inc. [AKBA] share price is $1.59. The Score for AKBA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Akebia Therapeutics, Inc. Stock Info
Market Cap:
421.9M
Price in USD:
1.59
Share Volume:
2M
Akebia Therapeutics, Inc. 52-Week Range
52-Week High:
4.08
52-Week Low:
1.45
Sell
35
Akebia Therapeutics, Inc. (AKBA)
is a Sell
Akebia Therapeutics, Inc. Share Price Forecast
-
What is the Akebia Therapeutics, Inc. stock price today?The Akebia Therapeutics, Inc. stock price is 1.59 USD today.
-
Will AKBA stock go up or go down?Akebia Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Akebia Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akebia Therapeutics, Inc. is overvalued.
Is Akebia Therapeutics, Inc. Stock a Buy?
-
Akebia Therapeutics, Inc. share price is 1.59 while AKBA 8-day exponential moving average is 1.57, which is a Buy signal.
-
The stock price of AKBA is 1.59 while Akebia Therapeutics, Inc. 20-day EMA is 1.74, which makes it a Sell.
-
Akebia Therapeutics, Inc. 50-day exponential moving average is 2.17 while AKBA share price is 1.59, making it a Sell technically.
-
AKBA stock price is 1.59 and Akebia Therapeutics, Inc. 200-day simple moving average is 2.54, creating a Sell signal.
Fundamental Analysis of Akebia Therapeutics, Inc.
Is Akebia Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.13 per share.
Technical Analysis of Akebia Therapeutics, Inc.
Should I short Akebia Therapeutics, Inc. stock?
-
AKBA Moving Average Covergence Divergence (MACD) indicator is -0.23, suggesting Akebia Therapeutics, Inc. is a Sell
-
Akebia Therapeutics, Inc. Relative Strength Index (RSI) is 36.06, which suggest Akebia Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Akebia Therapeutics, Inc. is (1.53 - 1.99), which suggest Akebia Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Akebia Therapeutics, Inc. is (2.11 - 3.49), which suggest Akebia Therapeutics, Inc. is a Sell
* Akebia Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.